These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 18482025)
1. Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate. Shank RP; Maryanoff BE CNS Neurosci Ther; 2008; 14(2):120-42. PubMed ID: 18482025 [TBL] [Abstract][Full Text] [Related]
2. Topiramate: a review of its use in the treatment of epilepsy. Lyseng-Williamson KA; Yang LP Drugs; 2007; 67(15):2231-56. PubMed ID: 17927286 [TBL] [Abstract][Full Text] [Related]
3. [Pharmacy clinics. Medication of the month. Topiramate (Topamax)]. Sadzot B Rev Med Liege; 2000 Feb; 55(2):114-6. PubMed ID: 10769582 [TBL] [Abstract][Full Text] [Related]
4. [Characteristics and indications of topiramate]. Nieto-Barrera M Rev Neurol; 2002 Sep; 35 Suppl 1():S88-95. PubMed ID: 12373660 [TBL] [Abstract][Full Text] [Related]
5. Weight loss of 172 lb with topiramate in a patient with migraine headaches. Khandalavala B; Spangler M Am J Health Syst Pharm; 2012 Mar; 69(5):367-8. PubMed ID: 22345412 [No Abstract] [Full Text] [Related]
8. [Neuroprotective effects of topiramate]. Pappalardo A; Liberto A; Patti F; Reggio A Clin Ter; 2004; 155(2-3):75-8. PubMed ID: 15244111 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs. Johannessen SI Epilepsia; 1997; 38 Suppl 1():S18-23. PubMed ID: 9092953 [TBL] [Abstract][Full Text] [Related]
10. Topiramate: its pharmacological properties and therapeutic efficacy in epilepsy. Latini G; Verrotti A; Manco R; Scardapane A; Del Vecchio A; Chiarelli F Mini Rev Med Chem; 2008 Jan; 8(1):10-23. PubMed ID: 18220981 [TBL] [Abstract][Full Text] [Related]
11. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease. Bays H Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765 [TBL] [Abstract][Full Text] [Related]
12. What's the role of topiramate in the management of patients with hyperkinetic movement disorders? Siniscalchi A; Gallelli L; Giofrè C; De Sarro G Pharmacol Rep; 2012; 64(1):24-30. PubMed ID: 22580517 [TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of topiramate in migraine prevention. Ferrari A; Tiraferri I; Neri L; Sternieri E Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1169-81. PubMed ID: 21756204 [TBL] [Abstract][Full Text] [Related]
14. Drug interaction profile of topiramate. Bourgeois BF Epilepsia; 1996; 37 Suppl 2():S14-S17. PubMed ID: 8641241 [TBL] [Abstract][Full Text] [Related]
15. Topiramate: a review of preclinical, pharmacokinetic, and clinical data. Rosenfeld WE Clin Ther; 1997; 19(6):1294-308. PubMed ID: 9444441 [TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of topiramate: a review. Garnett WR Epilepsia; 2000; 41(S1):61-5. PubMed ID: 10768303 [TBL] [Abstract][Full Text] [Related]
17. Preliminary observations on topiramate in pediatric epilepsies. Glauser TA Epilepsia; 1997; 38 Suppl 1():S37-41. PubMed ID: 9092958 [TBL] [Abstract][Full Text] [Related]
18. Molecular pharmacology of topiramate: managing seizures and preventing migraine. White HS Headache; 2005 Apr; 45 Suppl 1():S48-56. PubMed ID: 15833090 [TBL] [Abstract][Full Text] [Related]
19. Topiramate: a new antiepileptic drug. Privitera MD Ann Pharmacother; 1997 Oct; 31(10):1164-73. PubMed ID: 9337443 [TBL] [Abstract][Full Text] [Related]
20. Topiramate and metabolic acidosis. Wilner A; Raymond K; Pollard R Epilepsia; 1999 Jun; 40(6):792-5. PubMed ID: 10368081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]